The lowdown: Though its effectiveness in the management of chronic pain (including migraine headaches) has added to its sales, botulinum toxin continues to see skyrocketing revenue, thanks in large part to the neurotoxin’s renown as a certain noninvasive cosmetic procedure. According to Fortune Business Insights, sales of the runaway train commonly known by patients as
Spa Talk: Acqualina


